Engineering new bone growth using specific microRNAs
Official title: New craniofacial bone engineering through miR-23-27-24 cluster mediated osteogenic angiogenic coupling
Funded at University of Rochester · NIH-10911001 · Data updated 2026-11-12
This study is exploring how tiny molecules called microRNAs can help grow new bone and blood vessels at the same time, which could lead to better treatments for people with large bone injuries or defects.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project start | September 26, 2023 |
| Project end | May 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $358,435 |
| NIH project number | 5R01DE027686-06 |
| Project ID | NIH-10911001 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients with significant bone loss or defects, such as those resulting from trauma, surgery, or certain diseases.
✕Less likely to help
Patients with stable bone conditions or those not experiencing bone regeneration issues may not benefit from this research.
What this research studies
This research focuses on using microRNAs to enhance the growth of new bone tissue by promoting the formation of blood vessels and bone simultaneously. The approach involves targeting specific molecular pathways that regulate bone formation and resorption, aiming to develop new therapies for large bone defects. By studying the miR-23-27-24 microRNA cluster, the research seeks to understand how these molecules can be used to stimulate bone regeneration and improve healing in affected areas.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that significantly improve bone healing and regeneration for patients with large bone defects.
How similar studies have gone: Other research has shown promising results using microRNAs for bone regeneration, indicating that this approach has potential based on previous successes.
Where this research is happening
-
University of Rochester
Rochester, United States Active
Researchers
- Principal investigator: Luan, Xianghong — University of Rochester
- Study coordinator: Luan, Xianghong
Related research
Other NIH-funded projects on the same topics.
-
Rapid automated breast lump diagnosis without a radiologist or sonographer
A new AI-powered ultrasound tool helps determine if a palpable breast lump is likely benign or malignant, using a simplified technique that can be used by people with minimal ultrasound training.
-
ML-ROVER: Reducing Unneeded Lab Tests in Kids with AI
Aims to use machine learning to cut unnecessary blood tests in children in intensive care, helping avoid anemia and improve care quality.
-
Aggressive fever-reducing therapy to protect the brains of children with CNS malaria
A study planned for children with CNS malaria will test whether aggressive fever-reducing treatment can lower death and brain-related problems.
-
Aggressive fever-reducing therapy to protect brains in children with CNS malaria
A plan to test whether giving strong fever-reducing medications to children with central nervous system malaria can lower death and brain injury.
-
Aggressive fever-fighting treatment to protect the brain in kids with CNS malaria
A plan to test whether giving strong fever-reducing treatment alongside standard care can lower death and brain injury in children with CNS malaria.
-
Aggressive fever-reducing treatment to protect brains in kids with CNS malaria
A plan to test whether giving strong fever-reducing medicine alongside standard malaria treatment can lower deaths and brain injuries in children with CNS malaria.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.